← Insider buys
KPTI

Karyopharm Therapeutics Inc. · Healthcare

CEO Michael Kauffman sold $128K of Karyopharm Therapeutics Inc.

Sold$127,824
$10.23Price
12,500Shares
−1%Stake

What KPTI did after the filing

Prices for KPTI after this filing aren't in yet.

Traded Mon, Jan 7. Filed Wed, Jan 9, 11:41 AM ET, during the session. Not investment advice.